Mammography screening matters for young women with breast carcinoma: Evidence of downstaging among 42-49-year-old women with a history of previous mammography screening

Cancer

Volumn 97, Issue 2, 2003, Pages 352-358

  Buseman, Sandra ^a   Mouchawar, Judy ^b   Calonge, Ned ^c   Byers, Tim ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b KAISER PERMANENTE   (United States)

^c Colorado Department of Public Health and Environment ^*  (United States)

Author keywords

Adult; Breast neoplasm; Female; Mammography; Multivariate analysis; Neoplasm staging; Outcome assessment

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; FAMILY HISTORY; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; ONSET AGE; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL MODEL;

EID: 0037439361     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11050     Document Type: Article

References (59)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA. 2002;52:23-45.
2. Feig SA. Mammographic screening of women aged 40-49 years: is it justified? Obstet Gynecol Clin North Am. 1994;21:587-606.
3. DeKoning HJ, Frachegoud J, Boer R, et al. Nation-wide breast cancer screening in The Netherlands: support for breast cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB). Int J Cancer. 1995;60:777-780.
4. Sickes EA. Breast cancer screening outcomes in women ages 40-49: clinical experience with service screening using modern mammography. J Natl Cancer Inst Monogr. 1997;22:99-104.
5. Smith RA. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA. 2000;50:312-336.
6. Navarro AM, Kaplan RM. Mammography screening: prospects and opportunity costs. Womens Health. 1996;2:209-233.
7. Leitch AM. Breast cancer screening: success amid conflict. Surg Oncol Clin North Am. 1999;8:657-672.
8. Sickles EA, Kopans DB. Mammographic screening for women aged 40 to 49 years: the primary care practitioner's dilemma. Ann Intern Med. 1995;122:534-538.
9. Shapiro S. Periodic screening for breast cancer: the HIP randomized control trial. Health Insurance Plan. J Natl Cancer Inst Monogr. 1997;22:27-30.
10. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmo mammographic screening program. J Natl Cancer Inst Monogr. 1997;22:63-67.
11. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology. J Med Screen. 1995;2:94-98.
12. Alexander FE. The Edinburgh randomized trial of breast cancer screening. J Natl Cancer Inst Monogr. 1997;22:31-35.
13. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study: update on breast cancer mortality. J Natl Cancer Inst Monogr. 1997;22:37-41.
14. Frisell J, Lindbrink E. The Stockholm mammographic screening trial: risks and benefits in age group 40-49 years. J Natl Cancer Inst Monogr. 1997;22:49-51.
15. Bjurstam N, Bjorneld L, Duffy SW, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer. 1997;80:2091-2099.
16. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355:129-134.
17. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA. 1995;273:149-154.
18. Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA. Benefit of mammography screening in women ages 40-49 years: current evidence from randomized controlled trials. Cancer. 1995;75:1619-1625.
19. Glasziou PP, Woodward AJ, Mahon CM. Mammographic screening trials for women aged under 50. A quality assessment and meta-analysis. Med J Aust. 1995;162:625-629.
20. Glasziou PP, Irwig L. The quality and interpretation of mammographic screening trials for women ages 40-49. J Natl Cancer Inst Monogr. 1997;22:73-77.
21. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials. 1993;Doc No 32.
22. Hendrick RE, Smith RA, Rutledge JH 3rd, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr. 1997;22:87-92.
23. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet. 2002;359:909-919.
24. Letton AH, Mason EM, Ramshaw BJ. Twenty-year review of a breast cancer screening project: ninety-five percent survival of patients with nonpalpable cancers. Cancer. 1996;77:104-106.
25. Smart CR, Byrne C, Smith FA, et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Projects. CA. 1997;47:134-149.
26. Taber L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammography screening for breast cancer. Radiol Clin North Am. 1992;30:187-210.
27. Shapiro S, Venet W, Strax P, et al. Periodic screening for breast cancer: the Health Insurance Plan project and its sequelae, 1963-1986. Baltimore, MD: Johns Hopkins University Press, 1988.
28. Curpen BN, Sickles EA, Sollitto RA, Ominsky SH, Galvin HB, Frankel SD. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. AJR Am J Roentgenol. 1995;164:1099-1103.
29. Wazer DE, Gage I, Homer MJ, Krosnick SH, Schmid C. Age-related differences in patients with nonpalpable breast carcinomas. Cancer. 1996;78:1432-1437.
30. Thurfjell EL, Lindgren JA. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years. Radiology. 1996;201:421-426.
31. Smart CR. Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer. 1994;74:296-300.
32. Chu CK, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst. 1988;80:1125-1132.
33. Smith RA, Cokkinides V, von Eschenbach AC, et al. American Cancer Society guidelines for the early detection of cancer. CA. 2002;52:8-22.
34. Council of Scientific Affairs, American Medical Association. Mammographic screening in asymptomatic women aged 40 years and older. JAMA. 1989;261:2535-2542.
35. American College of Obstetricians and Gynecologists. The obstetrician-gynecologist and primary-preventive health care. Washington, DC: American College of Obstetricians and Gynecologists, 1993.
36. Screening for breast cancer. Recommendations and rationale. Rockville, MD: Agency for Healthcare Research and Quality, 2002. Available from URL: http://www.ahrq.gov/clinic/3rduspstf/breastcancer [accessed March 1, 2002].
37. Fleming ID, Cooper JS, Henson DE, et al., editors. American Joint Committee on Cancer staging manual, 5th edition. Philadelphia: J.B. Lippincott, 1997.
38. Fagerberg G, Baldetorp L, Grontoft O, Lundstrom B, Manson JC, Nordenskjold B. Effects of repeated mammographic screening on breast cancer stage distribution: results from a randomized study of 92, 934 women in a Swedish county. Acta Radiol Oncol. 1985;24:465-473.
39. Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985;1:829-832.
40. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ. 1988;297:943-948.
41. Ng EH, Ng FC, Tan PH, et al. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project. Cancer. 1998;82:1521-1528.
42. Parker RG, Leung KM, Rees KS, Bassett LW, Legorreta AP. Mammographic screening downstages breast carcinomas at time of diagnosis: a community based experience. Breast J. 1999;5:359-363.
43. Wu Y, Weissfeld JL, Weinberg GB, Kuller LH. Screening mammography and late-stage breast cancer: a population-based study. Prev Med. 1999;28:572-578.
44. Solin LJ, Schultz DJ, Kessler HB, Hanchak NA. Downstaging of breast carcinomas in older women associated with mammographic screening. Breast J. 1999;5:94-100.
45. McCarthy EP, Burns RB, Freund KM, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc. 2000;48:1226-1233.
46. Vacek PM, Geller BM, Weaver DL, Foster RS. Increased mammography use and its impact on earlier breast cancer in Vermont, 1975-1999. Cancer. 2002;94:2160-2168.
47. Robertson FM, Romanow J, Otchy DP, Walters MJ. Effect of mass screening mammography on staging of carcinoma of the breast in women. Surg Gynecol Obstet. 1990;171:55-58.
48. Kricker A, Farac K, Smith D, Sweeny A, McCredie M, Armstrong BK. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening. Int J Cancer. 1999;81:877-880.
49. Cody HS 3rd. The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993: equal value for patients younger and older than age 50 years. Cancer. 1995;76:1579-1584.
50. Cady B. New era in breast cancer: impact of screening on disease presentation. Surg Oncol Clin North Am. 1997;6:195-202.
51. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg. 1996;131:301-308.
52. Chang HR, Cole B, Bland KI. Nonpalpable breast cancer in women aged 40-49 years: a surgeon's view of benefits from screening mammography. J Natl Cancer Inst Monogr. 1997;22:145-149.
53. Morimoto T, Sasa M, Yamguchi T, Kondo H, Akaiwa H, Sagara Y. Breast cancer screening by mammography in women aged under 50 years in Japan. Anticancer Res. 2000;20:3689-3694.
54. Klemi PJ, Toikkanen S, Rasanen O, Parvinen I, Joensuu H. Mammography screening interval and the frequency of interval cancers in a population-based screening. Br J Cancer. 1997;75:762-766.
55. Norden T, Thurfjell E, Hasselgren M, et al. Mammographic screening for breast cancer: what cancers do we find? Eur J Cancer. 1997;33:624-628.
56. McPherson CP, Swenson KK, Jolitz-Murray CL. Survival of women ages 40-49 years with breast carcinoma according to method of detection. Cancer. 1997;79:1923-1932.
57. Byrne C, Smart CR, Chu KC, Hartmann WH. Survival advantage differences by age: evaluation of the extended follow-up of the Breast Cancer Detection Demonstration Project. Cancer. 1994;74:301-310.
58. Maibenco D, Daoud Y, Phillips E, Saxe A. Relationship between method of detection of breast cancer and stage of disease, method of treatment, and survival in women aged 40 to 49 years. Am Surg. 1999;65:1061-1066.
59. National Institutes of Health Consensus Conference: treatment of early stage breast cancer. JAMA. 1991;265:391-395.